 |
|
Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
So Yeon Kim
Clin Mol Hepatol. 2020;26(3):309-311. Published online 2020 Jun 15 DOI: https://doi.org/10.3350/cmh.2020.0061
|
|
Citations to this article as recorded by
 Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Hyo Jung Cho, Young Hwan Ahn, Min Suh Sim, Jung Woo Eun, Soon Sun Kim, Bong Wan Kim, Jimi Huh, Jei Hee Lee, Jai Keun Kim, Buil Lee, Jae Youn Cheong, Bohyun Kim
Gut and Liver.2022; 16(2): 277. CrossRef Update on MR Contrast Agents for Liver Imaging
Ashley Kalor, Rossano Girometti, Ekta Maheshwari, Andrea Siobhan Kierans, Rosa Alba Pugliesi, Christopher Buros, Alessandro Furlan
Radiologic Clinics of North America.2022; 60(5): 679. CrossRef Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis
Dong Hwan Kim, Bohyun Kim, Seo Yeon Youn, Hokun Kim, Joon-Il Choi
Diagnostics.2021; 11(10): 1763. CrossRef Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk
Cancers.2020; 12(11): 3347. CrossRef
|